Search Orphan Drug Designations and Approvals
-
Generic Name: | humanized immunoglobulin G1 (IgG1) T-cell bispecific (TCB) antibody targeting carcinoembryonic antigen (CEA) |
---|---|
Date Designated: | 01/22/2018 |
Orphan Designation: | Treatment of gastric cancer, including gastroesophageal junction cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Genentech, Inc. 1 DNA Way MS 35-5E South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-